Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Net Income (Continuing Operations) : $288 Mil (TTM As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Shandong Weigao Group Medical Polymer Co's Net Income (Continuing Operations) for the six months ended in Dec. 2023 was $115 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was $288 Mil.

Shandong Weigao Group Medical Polymer Co Net Income (Continuing Operations) Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Net Income (Continuing Operations) Chart

Shandong Weigao Group Medical Polymer Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

274.50

337.50

385.88

423.16

288.73

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income (Continuing Operations)	Get a 7-Day Free Trial															181.91	248.63	184.39	173.58	114.64

Shandong Weigao Group Medical Polymer Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $288 Mil.

Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Shandong Weigao Group Medical Polymer Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (OTCPK:SHWGY) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

SHWGF:USA 01066:Hong Kong UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Headlines

From GuruFocus

ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products

By PRNewswire PRNewswire • 04-08-2019

Shandong Weigao Group Medical Polymer Co Ltd's Dividend Analysis

By GuruFocus Research • 10-26-2023